Search Results

The Allen Institute for Cell Science unveiled a set of tools to accelerate research into hypertrophic cardiomyopathy, the most common genetic heart condition in the world: six new cell line collections, each carrying a different mutation associated with HCM.

Oct. 9, 2023 at their annual general meeting, the National Academy of Medicine announced the election of Hongkui Zeng, Ph.D, Allen Institute’s Executive Vice President and Director of the Allen Institute for Brain Science, to their membership for her leading role in understanding the cell types and the functional architecture of the mammalian brain.

The Allen Institute has officially become the newest member of the Weill Neurohub, a collaborative research network advancing treatments for neurological diseases.

Booz Allen Hamilton announced it was awarded a seven-year, $419 million contract with the National Science Foundation for Information Technology Mission Application Support.

New research by scientists at the Allen Institute’s Brain and Consciousness group and Cedars-Sinai offers an unprecedented look at how neurons respond to ES.

Scientists from the Allen Institute for Neural Dynamics, a division of the Allen Institute, launched the world’s first completely open- and crowd-sourced neuroscience experiment—inviting researchers from around the world to publicly design a shared experiment that will run on the Allen Brain Observatory, as part of the Institute’s OpenScope program.

The Dana Foundation Launches Neurotech Justice Accelerator at Mass General Brigham (NJAM) to Unite Science and Society and Mitigate Medical, Legal, and Ethical Risks

The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene therapy Kebilidi for AADC deficiency. It is the first approved gene therapy to be delivered directly to the brain.

With pediatric inflammatory bowel disease diagnoses on the rise globally, a clinical trial in Seattle aims to transform treatment approaches through deep molecular profiling.

This Sunday at 2:37 p.m. PDT1, astronauts from Axiom Space in partnership with Cedars-Sinai will blast off to the International Space Station carrying cells from the Allen Institute for Cell Science, a division of the Allen Institute.